1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Dry Eye Products Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Dry Eye Products Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Dry Eye Products Market Regional Analysis
6.2 Middle East & Africa Dry Eye Products Market Revenue 2021-2031 (US$ Million)
6.3 Middle East & Africa Dry Eye Products Market Forecast Analysis
7. Middle East & Africa Dry Eye Products Market Analysis – by Product
7.1 Artificial Tears
- 7.1.1 Overview
- 7.1.2 Artificial Tears: Middle East & Africa Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Anti-Inflammatory Drugs
- 7.2.1 Overview
- 7.2.2 Anti-Inflammatory Drugs: Middle East & Africa Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Punctal Plugs
- 7.3.1 Overview
- 7.3.2 Punctal Plugs: Middle East & Africa Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Secretagogues
- 7.4.1 Overview
- 7.4.2 Secretagogues: Middle East & Africa Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Oral Omega Supplements
- 7.5.1 Overview
- 7.5.2 Oral Omega Supplements: Middle East & Africa Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Middle East & Africa Dry Eye Products Market Analysis – by Dosage Form
8.1 Eye Drops
- 8.1.1 Overview
- 8.1.2 Eye Drops: Middle East & Africa Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Gel
- 8.2.1 Overview
- 8.2.2 Gel: Middle East & Africa Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Capsules
- 8.3.1 Overview
- 8.3.2 Capsules: Middle East & Africa Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Tablets
- 8.4.1 Overview
- 8.4.2 Tablets: Middle East & Africa Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Middle East & Africa Dry Eye Products Market Analysis – by Type
9.1 OTC and Prescription
- 9.1.1 Overview
- 9.1.2 OTC and Prescription: Middle East & Africa Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Middle East & Africa Dry Eye Products Market Analysis – by Distribution Channel
10.1 Retail Pharmacy
- 10.1.1 Overview
- 10.1.2 Retail Pharmacy: Middle East & Africa Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.2 Hospital Pharmacy
- 10.2.1 Overview
- 10.2.2 Hospital Pharmacy: Middle East & Africa Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Online Pharmacy
- 10.3.1 Overview
- 10.3.2 Online Pharmacy: Middle East & Africa Dry Eye Products Market – Revenue and Forecast, 2021-2031 (US$ Million)
11. Middle East & Africa Dry Eye Products Market – Middle East and Africa Analysis
11.1 Overview
11.2 Middle East and Africa
- 11.2.1 Middle East & Africa Dry Eye Products Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 11.2.1.1 Middle East & Africa Dry Eye Products Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 South Africa:
Middle East & Africa Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.1.1 South Africa: Middle East & Africa Dry Eye Products Market Breakdown, by Product
- 11.2.1.1.2 South Africa: Middle East & Africa Dry Eye Products Market Breakdown, by Dosage Form
- 11.2.1.1.3 South Africa: Middle East & Africa Dry Eye Products Market Breakdown, by Type
- 11.2.1.1.4 South Africa: Middle East & Africa Dry Eye Products Market Breakdown, by Distribution Channel
- 11.2.1.2 Saudi Arabia:
Middle East & Africa Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.2.1 Saudi Arabia: Middle East & Africa Dry Eye Products Market Breakdown, by Product
- 11.2.1.2.2 Saudi Arabia: Middle East & Africa Dry Eye Products Market Breakdown, by Dosage Form
- 11.2.1.2.3 Saudi Arabia: Middle East & Africa Dry Eye Products Market Breakdown, by Type
- 11.2.1.2.4 Saudi Arabia: Middle East & Africa Dry Eye Products Market Breakdown, by Distribution Channel
- 11.2.1.3 UAE:
Middle East & Africa Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.3.1 UAE: Middle East & Africa Dry Eye Products Market Breakdown, by Product
- 11.2.1.3.2 UAE: Middle East & Africa Dry Eye Products Market Breakdown, by Dosage Form
- 11.2.1.3.3 UAE: Middle East & Africa Dry Eye Products Market Breakdown, by Type
- 11.2.1.3.4 UAE: Middle East & Africa Dry Eye Products Market Breakdown, by Distribution Channel
- 11.2.1.4 Rest of Middle East and Africa:
Middle East & Africa Dry Eye Products Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Dry Eye Products Market Breakdown, by Product
- 11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Dry Eye Products Market Breakdown, by Dosage Form
- 11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Dry Eye Products Market Breakdown, by Type
- 11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Dry Eye Products Market Breakdown, by Distribution Channel
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Santen Pharmaceutical Co Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Johnson & Johnson
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 OASIS Medical
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 URSAPHARM Arzneimittel GmbH
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Rohto Pharmaceutical Co Ltd
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 OCuSOFT Inc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Bausch Health Companies Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 AbbVie Inc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Farmigea SpA
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Alcon AG
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations